Document text
Principal Investigator: qing sun
Organization: TEXAS ENGINEERING EXPERIMENT STATION
Fiscal Year: 2023
Award: $360,295
Funding agency: National Institute of Allergy and Infectious Diseases
Among all approaches, messenger RNA (mRNA)-based vaccines have emerged as a rapid and versatile
candidate to quickly respond to virus pandemics, including coronavirus disease 2019 (COVID-19). But mRNA
vaccines face key potential limitations. Researchers have observed that RNA molecules tend to spontaneously
degrade, which is a serious limitation - a single cut in the mRNA backbone can nullify the mRNA vaccine.
Currently, little is known on the details of where in the backbone of a given RNA is most prone to degradation
and design of super stable messenger RNA molecules is an urgent challenge. Without this knowledge, mRNA
vaccines against COVID-19 will require stringent conditions for preparation, storage, and transport. A promising
potential solution is deep learning, a general class of data-driven modeling approach, which has proved dominant
in many fields including computer vision, natural language processing, protein folding, and nucleic acid feature
prediction tasks. In this proposal, Dr. Qing Sun aims to combine deep learning and experiments to predict mRNA
vaccines that are stable at room temperature. By adapting two deep learning techniques including self-attention
and convolutions, she will create interpretable end to end models to predict COVID-19 vaccine secondary
structures directly from sequence information and in the end, she will use a synthetic approach that rapidly
generates mRNA vaccine to validate and further improve their deep learning model. Specifically, the research
objectives of this proposal are: 1) to develop the deep learning model using self-attention and convolution, which
capture long-range dependencies, to predict RNA secondary structures and to train the model using existing
RNA secondary structure dataset with high accuracy and efficiency; 2) to employ transfer learning for mRNA
vaccine stability predictions; and 3) to validate and further improve the model performance using experimental
demand-based mRNA production system. She will produce hundreds of mRNA vaccines sequences and test
their stabilities in the lab to serve as dataset to validate and retrain their model. This project will serve as a
framework for other mRNA vaccine processing for rapid response to pandemics. The secondary structure
prediction knowledge from this proposal will also help characterize natural mRNA and synthetic mRNA for natural
science and engineering purposes.
Terms: <2019-nCoV vaccine><Adopted><Anti-Bacterial Agents><Antibacterial Agents><Attention><COVID-19><COVID-19 vaccine><COVID19><COVID19 vaccine><CV-19><CV19><Chemicals><Code><Coding System><Cold Chains><Communicable Diseases><Computer Vision Systems><Data><Data Set><Dependence><Developing Countries><Developing Nations><Development and Research><ELISA><Engineering><Enzyme-Linked Immunosorbent Assay><Face><Feedback><Fluorescence><Functional RNA><Gene Transcription><Genetic Transcription><Half-Life><Hydrolysis><Immunoblotting><Immunogenetics><In Vitro><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Investigators><Knowledge><Learning><Length><Less-Developed Countries><Less-Developed Nations><Mammalian Cell><Messenger RNA><Methods><Modeling><Natural Language Processing><Natural Sciences><Non-Coding><Non-Coding RNA><Non-Polyadenylated RNA><Non-translated RNA><Noncoding RNA><Nontranslated RNA><Nucleic Acids><Performance><Physics><Preparation><Process><Production><Property><Proteins><R & D><R&D><RNA><RNA Degradation><RNA Expression><RNA Gene Products><RNA Instability><RNA Sequences><RNA Stability><RNA based therapeutics><RNA based therapy><RNA therapy><RNA vaccine><RNA-based vaccine><Research><Research Personnel><Researchers><Rest><Ribonucleic Acid><Role><SARS-CoV-2 vaccine><SARS-CoV2 vaccine><SARS-coronavirus-2 vaccine><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe acute respiratory syndrome coronavirus 2 vaccine><Spinal Column><Spine><Structure><System><Techniques><Temperature><Testing><Third-World Countries><Third-World Nations><Training><Transcription><Translations><Under-Developed Countries><Under-Developed Nations><Untranslated RNA><Update><Vaccine Production><Vaccines><Validation><Variant><Variation><Vertebral column><Viral><Viral Activity><Viral Function><Viral Physiology><Western Blotting><Western Immunoblotting><Work><anti-bacterial><antibacterial><backbone><computer vision><corona virus disease 2019><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 vaccine><coronavirus disease-19><coronavirus disease-19 vaccine><coronavirus infectious disease-19><cost><data-driven model><deep learning><deep learning based model><deep learning model><design><designing><develop a vaccine><develop vaccines><developing country><developing nation><development of a vaccine><enzyme linked immunoassay><experiment><experimental research><experimental study><experiments><faces><facial><fighting><improved><in vivo><mRNA><mRNA vaccine><mRNA-based vaccine><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><natural language understanding><noncoding><novel><pandemic><pandemic disease><pandemic virus><preparations><produce vaccines><protein blotting><protein folding><research and development><response><rural area><rural location><rural region><social role><supervised learning><supervised machine learning><therapeutic RNA><transfer learning><translation><tumor><unsupervised learning><unsupervised machine learning><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine development><vaccine for novel coronavirus><validations>